Curepro Parenterals Limited, a amalgamated public limited company, was established on 19 April 2013 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2013PLC087101. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹13.31 Cr.
It upholds a compliant status. Its leadership includes Madan Mohan Reddy Mettu (Director), Sivakumaran Meenakshisunderam (Director), Bhanu Murthy Chavali (Whole-Time Director). Past directors included Govindarajan Narayanan, Nityananda Reddy Kambam, Sivakumaran Meenakshisunderam. Its latest AGM occurred on 24 August 2020, with the balance sheet filed on 31 March 2020. It is based at Plot No.2, Maitrivihar Ameerpet, Hyderabad, Telangana, 500038.
U24232TG2013PLC087101
087101
19 April 2013
₹20.00 Cr
₹13.31 Cr
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Curepro Parenterals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madan Mohan Reddy Mettu | Director | 21 Aug 2013 | Current |
| Sivakumaran Meenakshisunderam | Director | 25 Jun 2015 | Current |
| Bhanu Murthy Chavali | Whole-Time Director | 27 May 2019 | Current |
| Sarath Chandra Reddy Penaka | Director | 12 Sep 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Aug 2013 | Past |
| Pramod Abcsdd | Director | 22 Aug 2013 | Past |
| Pramod Abcsdd | Additional Director | 24 Aug 2015 | Past |
| Pramod Abcsdd | Director | 12 Sep 2013 | Past |
| Pramod Abcsdd | Director | 25 Jun 2015 | Past |
| Pramod Abcsdd | Key Managerial Personnel | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Curepro Parenterals Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 28752.27% decrease in profit. The company's net worth dipped by a decrease of 0.64%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Curepro Parenterals had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Curepro Parenterals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Curepro Parenterals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curepro Parenterals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Curepro Parenterals Limited last Annual general meeting of members was held on 24 Aug 2020 as per latest MCA records. was recorded as a recent event.
Srinivasarao Devathi was appointed as a CFO was appointed as a CFO on 21 May 2020 & has been associated with this company since 5 years 6 months . was recorded as a recent event.
The activity Curepro Parenterals Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad. was completed.
Venkat Reddy Kupireddy was appointed as a Company Secretary was appointed as a Company Secretary on 10 Jun 2019 & has been associated with this company since 6 years 5 months . was recorded as a recent event.
Bhanu Murthy Chavali was appointed as a Whole-time director was appointed as a Whole-time director on 27 May 2019 & has been associated with this company since 6 years 6 months . was recorded as a recent event.
Sivakumaran Meenakshisunderam was appointed as a Director was appointed as a Director on 25 Jun 2015 & has been associated with this company since 10 years 5 months . was recorded as a recent event.
The CIN of Curepro Parenterals Limited is U24232TG2013PLC087101.
Curepro Parenterals Limited is headquartered at Plot No.2, Maitrivihar Ameerpet, Hyderabad, Telangana, 500038.
Curepro Parenterals Limited was incorporated on 19 April 2013.
The current directors of Curepro Parenterals Limited are
The primary industry of Curepro Parenterals Limited is Manufacturing.
Curepro Parenterals Limited is unlisted.
The authorized capital of Curepro Parenterals Limited is ₹20.00 Cr, and the paid-up capital is ₹13.31 Cr.
The compliance status of Curepro Parenterals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX